Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Retrieved on: 2021-07-22 01:18:45

Tags for this article:

Click the tags to see associated articles and topics

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research. View article details on hiswai:

Excerpt

“The continuing evolution of circulating SARS-CoV-2 variants, often containing substitutions known to confer resistance to several monoclonal ...

Article found on: www.news-medical.net